The number of employees medicated for anxiety and depression rise by 5.7 percent over an existing base rate of 5.2 percent when pay is based on performance–and up 8.9 percent for older workers. (Photo: Shutterstock)

Employers across the country have been putting a lot more thought into their compensation programs in recent years, partially responding to the more-competitive market for talent, but also to increasing pay transparency among workers. Many have landed on a pay-for-performance model, which seems logical enough–at first glance.

A first-of-its-kind study from researchers at Washington University in St. Louis and Aarhus University in Denmark, found that a company that switches to a pay-for-performance process (which includes things like bonuses, commissions, piece rates, profit sharing, individual and team goal achievements or some other configuration) will also see a rise in the number of employees using anxiety and depression medication.

Researchers found that the number of employees medicated for anxiety and depression rise by 5.7 percent over an existing base rate of 5.2 percent. What's more, the effect was more pronounced in older workers, who experienced an 8.9 percentage increase over the base rate in prescriptions for benzodiazepines such as Xanax or selective serotonin reuptake inhibitors such as Zoloft. This could be because older workers lack as much labor mobility as younger ones, although it could also be due to less openness or resilience to such a change on their part compared to the younger, still developing workers.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Marlene Satter

Marlene Y. Satter has worked in and written about the financial industry for decades.